🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523980-39-00
Authorised Phase I

A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis

2025-523980-39-00 · tracked via the Priya Life Science EU tracker
Sponsor
Eli Lilly & Co.
Sponsor type
Pharmaceutical company
Therapeutic area
Immune System Diseases
Decision date
07/09/2026
Enrollment target
15
Sites
Germany

Condition studied

Rheumatoid arthritis (RA)

Eligibility

Age group
18-64 years, 65+ years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523980-39-00 on CTIS ↗ ← All trials in the EU